|
HS Code |
890825 |
| Chemical Name | Potassium Oxonate |
| Molecular Formula | C3H2KN3O4 |
| Molecular Weight | 199.17 g/mol |
| Cas Number | 3054-47-5 |
| Appearance | White to off-white crystalline powder |
| Solubility In Water | Soluble |
| Melting Point | Decomposes |
| Synonyms | 4-Pyrimidinecarboxylic acid, potassium salt; Oxonic acid potassium salt |
| Storage Conditions | Store at 2-8°C, protected from light |
| Usage | Chemotherapy adjuvant, uricase inhibitor |
| Ph | Neutral to slightly basic in aqueous solution |
| Stability | Stable under recommended storage conditions |
As an accredited Potassium Oxonate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Potassium Oxonate is packaged in a 25g amber glass bottle, sealed with a screw cap and labeled with hazard and identification information. |
| Shipping | Potassium Oxonate should be shipped in tightly sealed containers, protected from moisture and physical damage. Store and transport at room temperature, away from incompatible substances. Follow all applicable regulations for chemical transportation, including proper labeling and documentation. Ensure handlers use appropriate personal protective equipment during loading and unloading procedures. |
| Storage | Potassium Oxonate should be stored in a tightly closed container, in a cool, dry, and well-ventilated area away from moisture and incompatible substances such as strong oxidizing agents and acids. Protect from light and humidity. Store at room temperature unless otherwise specified by the manufacturer. Ensure proper labeling and keep the storage area secure and compliant with safety regulations. |
|
Purity 99%: Potassium Oxonate with 99% purity is used in pharmaceutical synthesis, where it ensures high-yield drug intermediate production. Molecular Weight 157.19 g/mol: Potassium Oxonate of molecular weight 157.19 g/mol is used in clinical research formulations, where it guarantees precise compound dosing. Particle Size <10 μm: Potassium Oxonate with particle size less than 10 μm is used in tablet manufacturing, where it promotes uniform dispersion and enhanced bioavailability. Stability Temperature 25°C: Potassium Oxonate stable at 25°C is used in long-term reagent storage applications, where it maintains consistent chemical integrity. Melting Point 360°C: Potassium Oxonate with a melting point of 360°C is used in high-temperature synthesis processes, where it offers robust thermal stability. Solubility in Water 10 g/L: Potassium Oxonate with water solubility of 10 g/L is used in intravenous drug formulations, where it achieves rapid and complete dissolution. Low Heavy Metal Content <10 ppm: Potassium Oxonate with heavy metal content below 10 ppm is used in injectable pharmaceutical products, where it reduces toxicological risk. Loss on Drying <0.5%: Potassium Oxonate with loss on drying less than 0.5% is used in lyophilized medication preparations, where it ensures product consistency and longevity. |
Competitive Potassium Oxonate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Potassium oxonate doesn’t top most household chemical lists, yet in pharmaceutical labs and research circles, it’s a familiar name. In the realm of fine chemicals, a substance like this earns its place through reliability, consistency, and efficiency—attributes we all count on, regardless of our role in the chain from benchtop to clinic. Through my work in drug development, potassium oxonate has shown up several times, each instance reminding me how the unassuming details behind-the-scenes make all the difference when precision matters.
The product you get in the lab is usually potassium oxonate in a solid powder form. Its chemical formula, C3H2KN3O4, offers a balance of stability and reactivity, important traits for reproducible results in complex chemical syntheses. The purity of the compound matters. You find offerings from 98% up to 99.5%, tested through established analytical methods like HPLC or titration. High purity means less interference from side reactions, making sure your results track the intended pathway. Granule sizes range from finely divided to coarser crystals. I find the finer varieties dissolve easier in aqueous environments, giving a cleaner start in enzymatic assays or organic transformations.
Most conversations about potassium oxonate circle back to its starring role in drug synthesis, namely in chemotherapy protocols. One of its best-known uses is in combination with fluoropyrimidine-based drugs. Think about the journey to improve tolerability in patients receiving 5-fluorouracil (5-FU). Researchers learned early that potassium oxonate, as an orotate phosphoribosyltransferase (OPRT) inhibitor, reduces gastrointestinal side effects by interfering with local metabolism of 5-FU in the gut. Fewer symptoms, less discomfort, and patients more likely to see their treatment through. This substance doesn’t cure anyone by itself, but it quietly reshapes the patient experience.
Outside cancer therapy, potassium oxonate appears in studies of enzyme inhibition and metabolic testing. In animal models, especially mice and rats, labs use it to elevate uric acid levels and study hyperuricemia or gout models. Through blocking uricase, potassium oxonate creates a scenario resembling human disease. It’s not glamorous, but it’s extremely useful. Reliable animal models help screen new drugs, clarify mechanism of action, and set baselines for therapeutic improvements. You want a product that gives predictable, consistent effects, batch after batch. Over my years working with preclinical models, I can say with certainty: cutting corners on chemical quality always causes more headaches and wasted time than it saves up front.
The fine chemical market is full of similar-seeming compounds, so the conversation turns to trade-offs. In uricase inhibition experiments, alternative reagents such as oxonic acid or sodium oxonate can show up on shopping lists. Potassium oxonate, by comparison, offers better solubility in water as a potassium salt. This makes dosing straightforward in both in vitro and in vivo settings. Products without this property create uneven suspensions, leading to dose inconsistency or precipitation during administration. Participants in my teams have sometimes switched mid-project, realizing too late that the wrong salt form led to headaches calculating molar concentrations.
Pharmaceutical manufacturing respects these subtle differences. Potassium oxonate’s batch reproducibility makes regulatory documentation easier. No supervisor wants to explain an outlier HPLC trace to a regulatory auditor. I’ve discovered compound selection in early research impacts downstream scalability and compliance, so making careful choices now prevents big headaches down the road.
In daily use, potassium oxonate’s stability shines through. This chemical stores well in a dry, cool space. Sealed containers offer protection from humidity, since the powder absorbs water if given the chance. If you’ve handled similar salts, you know the value of consistent texture; clumping powders can throw off weigh-outs, especially for small-scale work in academic labs.
Measuring and dissolving potassium oxonate with common lab glassware rarely presents trouble. On my bench, a straightforward balance and a clean spatula suffice. If the powder starts out fine, adding it to buffered saline or simple distilled water leads to rapid dissolution. A clear solution signals it’s ready for further use, often as a co-factor or enzyme modulator in synthetic or biological systems.
Quality control stands at the center of trust in specialty chemicals like potassium oxonate. In high-stakes research and therapeutic manufacturing, even a small impurity profile creates problems during validation or toxicology assessments. Labs typically receive certificates of analysis, confirming the batch meets established benchmarks. HPLC traces chart out purity, flagging unexpected byproducts. Spectral data such as NMR or mass spectrometry provides reassurance that structure and composition match specification. These efforts amount to more than bureaucratic red tape. They help ensure that each trial, each study, and each manufactured batch starts with a known baseline.
Recalls, failed syntheses, or botched clinical lots can often be traced to poor quality or poorly sourced chemicals. So companies with a track record of stringent batch testing and transparent reporting tend to stick around. Over my years moving between university labs and commercial scale-up environments, product transparency was always rewarded with fewer troubleshooting loops and more predictable timelines. Not only does this boost internal credibility, it also builds confidence for regulatory filings.
The conversation around sustainable chemistry grows louder each year. Waste reduction, solvent choice, and overall environmental impact stay at the top of planning documents. Products like potassium oxonate, with easy dissolution and low hazardous byproduct profile, fit more comfortably into greener synthesis protocols. Labs benefit when legacy chemicals don’t force hazardous waste streams or complex disposal routines. Having fewer safety risks allows teams to work at scale, while keeping compliance manageable. This, in turn, echoes through industry as productivity gains and lower insurance premiums.
Many alternative chemicals on the market produce harsh byproducts, require aggressive pH control, or need complex disposal. Potassium oxonate, with its straightforward composition, often translates to a lighter regulatory load. My colleagues in process development tell me their teams appreciate simplicity, especially when workflows grow more automated. Using a compound that dovetails with modern waste management and health regulations is more than good citizenship—it’s a strategic advantage.
Potassium oxonate often flies under the radar in discussions about raw material sourcing, yet it plays a strategic role in the broader ingredient ecosystem supporting drug manufacturing and research pipelines. Steady demand for quality, fully traceable material underpins growth in both branded and generic drug programs. Supply chain disruptions typically show up quickly through price swings or temporary shortages. Facilities that rely on potassium oxonate for core research or production need to pay close attention to sourcing contracts, backup suppliers, and shelf life management.
The rise of localized supply chains during global disruptions, such as pandemic-era restrictions, forced a renewed audit of where and how specialty chemicals enter the workflow. Firms who diversify purchasing and maintain in-house quality checks weathered recent storms more smoothly. In my time consulting on procurement strategy, I noticed companies who meet regular with their vendors, compare certificates of analysis, and track lot numbers avoid production slowdowns and missed milestones. Those savings ripple to the rest of the operation, translating into lower final product costs and higher output reliability.
In the world of pharmaceutical chemicals, following regulatory expectations isn’t extra credit – it’s table stakes. Potassium oxonate enters regulated workflows in preclinical and clinical development, so every batch needs a validated pedigree. Agencies expect transparent reporting, good manufacturing practices, and detailed batch records. If a substance moves from research-grade work into large-scale production, new documentation hoops follow, from environmental audits to occupational exposure assessments.
Product labels read like a laundry list at times, but there’s no shortcutting safety. Potassium oxonate, like any chemical, needs respect and good handling practices. Gloves, lab coats, and dust control keep exposures minimal. Eye protection always stays close at hand. In years of research work, I’ve witnessed enough careless accidents to respect the process, even when working with materials that lack the outright danger of concentrated acids or volatile solvents. Knowing what you handle—through clear labeling, safety data sheets, and regular staff refreshers—sits at the core of good lab citizenship.
Tracking use and expiration dates matters, especially in regulated settings where every reagent, batch, and compound must connect back to clear records. Inventory management systems tie lot codes to specific research batches, supporting reproducibility. Failures in data tracking can unravel months of work. In labs where I supported audits, proper record keeping made the difference between a smooth review and days spent trying to rescue overlooked files. If potassium oxonate forms part of a drug submission or clinical batch, any questions over expiration or storage go right back through quality management. Knowing you have the supporting records close at hand brings peace of mind when timelines get compressed and stress runs high.
Potassium oxonate’s reach in research continues to grow, reflecting its reputation as a reliable metabolic modulator and enabling tool. Metabolic pathway analysis doesn’t sound thrilling in pitch decks, but the value shows up in how many successful new therapies rest on a bedrock of clear metabolic data. Research into combination regimens—including oral chemotherapy—uses potassium oxonate to manage local drug toxicity without changing efficacy in target tissues. The right use of this chemical helps design drugs more patients can tolerate. I’ve seen this translate from benchtop models through to human pilot studies, with data supporting better side effect profiles and higher adherence rates.
Enzyme assay design and high-throughput screening protocols also benefit from the precision potassium oxonate delivers. Whether run by hand or in automated screening suites, experiments built around predictable chemical behavior lead to more insightful conclusions. The closer a research tool matches its published standards, the more useful its results become—enabling constructive iteration rather than repeated troubleshooting.
Across countless industry meetings and supplier showcases, the old truth remains: all products are not created equal. Potassium oxonate’s name may offer a shorthand, but actual lot-to-lot consistency, documentation quality, and impurity controls differentiate leading suppliers from the underprepared. Research budgets grow tighter every year, and every misstep using cheaper, poorly characterized material grows more expensive in hindsight.
The research teams I’ve worked with prize the ability to call up a supplier and get clear answers about storage, purity methods, and cross-contamination risks. Companies who invest in open reporting and frank communication see that investment paid back with loyal, repeat buyers. Review forums, cross-lab collaboration networks, and published case studies help keep the signal visible amid industry noise. In my consulting work, lab managers frequently discover that up-front vetting and willingness to pay for quality prevents the silent spread of “hidden costs” that undermine even well-planned projects.
High-quality potassium oxonate creates more than smooth syntheses. It encourages a culture of care and integrity within research groups. When chemists can trust the building blocks, their troubleshooting focuses on the problems worth solving, not on time-consuming re-runs or chasing false negatives. This mental clarity lets teams push innovation further, secure grant extensions, and draw sharper boundaries in regulatory filings. It’s remarkable how a single well-sourced ingredient can anchor larger projects, pipeline progress, and discoveries benefiting patients down the road.
Sustaining a reputation for high standards in sourcing—potassium oxonate included—lets teams attract partnerships, investment, and talented recruits. As the fight to develop safer, more effective therapies continues, the attention to specialty ingredients pays off years after purchase orders clear. Detailed traceability, transparent data, and open communication mark the difference between short-lived success and lasting impact.
Potassium oxonate’s strengths don’t shield it from limitations. Some experiments require greater solubility in non-aqueous systems, or more rapid tissue penetration. Potassium oxonate’s strengths emerge in water-based, buffered environments; attempts to stretch its use past these parameters deliver diminishing returns. Chemists planning new protocols should evaluate whether its performance fits the specific needs of the experiment.
Through the years, teams get tempted by alternate reagents promising better yields or simpler cleanup. Experience shows those claims rarely pan out; short-term cost-savings too often result in wasted time, unexpected interactions, and extra analytical tests. Working with potassium oxonate gives the researcher a known variable, so any bumps in the project pathway come from factors you can control and explain.
Looking ahead, the field continues to evolve. Extended studies explore ways to harness potassium oxonate for better metabolic profiling, new drug conjugates, and next-generation tolerability enhancers. As chemical sourcing diversifies and analytical tools become more sensitive, access to higher purity standards expands. That means higher confidence at the bench and more options for cost-conscious buyers. University laboratories, contract drug manufacturers, and biotechnology start-ups all stand to gain from the broadening access to quality specialty chemicals.
Open science efforts and collaborative consortia also play a role. Sharing best practices, batch data, and lessons learned with potassium oxonate in published literature or open-access fora strengthens the scientific record. It becomes easier to compare outcomes, diagnose oddball results, and converge toward industry best practices.
Potassium oxonate’s widespread use merits practical tips. If powder texture seems off—clumpy or discolored—stop and check recent storage conditions before proceeding. Immediate quality control tests, whether a quick HPLC screen or solubility check, sometimes reveal humidity or cross-contamination from nearby chemicals. Small errors caught early save full project resets.
For teams managing multiple lots or long timelines, adopting barcode-based inventory and cross-checking against digital certificates of analysis keeps confusion low. Drawing on experience, every clear label and scanned file reduces late-night confusion when pressure mounts.
Solving solubility bottlenecks starts with gentle warming and careful stirring; harsh methods lead to degradation or contamination. Allot time for slow dissolution in buffer, especially when working with higher concentrations. Don’t over-rely on old solutions either—fresh dilutions make for cleaner baselines and less uncertainty in critical experiments.
Anyone scaling from milligram syntheses to multi-gram or kilo-scale production needs to confirm that batch source, impurity profile, and solubility methods stay consistent as volumes rise. Experience shows that small discrepancies compound quickly under new conditions. Engaging directly with technical support from vendors clarifies specifications not always visible in purchase documentation.
In laboratories and production facilities, the cumulative effect of well-chosen tools—potassium oxonate among them—shapes daily routines and long-term project outcomes. The science we trust, the breakthroughs patients wait for, all rest on sourcing choices that blend technical rigor with practical experience. So for those building tomorrow’s medicines or seeking to advance the understanding of metabolic disease, investing in proven specialty chemicals is less about chasing trends and more about honoring a tradition of reliable, reproducible progress.